Simcere Pharmaceutical IPO: Valuation Insights
We think that an attractive PEG valuation and solid cornerstone support makes Simcere tempting at the proposed pricing range
566 Views
Asia Short Interest Weekly - Big Jump in Japan Shorts
The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...
466 Views
Last Week in Event SPACE: Jardine Matheson, Vedanta, Cromwell, Cardinal, Taubman, Mediawan
Last Week in Event SPACE ... Jardine Matheson Holdings (JM SP)'s buybacks accelerate, suggesting now is the time to reverse the set-up trade...
611 Views
3SBio: The Frequent Board Turnover Is Just the Tip of the Iceberg of a Larger Governance Issue
3SBio, based in China develops, manufactures, markets and sells biopharmaceuticals. The company owns market-leading biopharmaceuticals franchises...
411 Views
3SBio: Valuation Trap with Tell-Tale Signs of Corporate Governance Issues
3SBio is a leading pharmaceutical company in China. It has a dominant market share in two of its key products. Recently, the company's share price...
463 Views